. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology. 2000 Dec 12;55(11):1644-9. PubMed.


Please login to recommend the paper.


  1. The difficulty we have had proving a role for the polymorphisms in the APOE promoter in AD (and the general consensus seems to be that they have a role), illustrates the difficulty we will have in determining whether genetic variability at other non-coding sites influences disease.

Make a Comment

To make a comment you must login or register.